A personalized, organ-based approach to the treatment of chronic steroid-refractory graft-versus-host disease
{{output}}
Chronic graft-versus-host-disease (cGvHD) remains the leading cause of morbidity among transplant recipients. The efficacy of second-line treatments varies widely based on many factors, including wide differences in the organ overall response-rate response and... ...
